Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 55.88m |
Free float | 55.34m |
P/E (TTM) | -- |
Market cap | 2.58bn USD |
EPS (TTM) | -2.21 USD |
--
More ▼
Announcements
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Third Quarter 2024 Results
- Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
- Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
- Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
- Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
- Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
- Enovis Announces Second Quarter 2024 Results
- Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
- Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
More ▼